Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights
Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quar...
Eli Lilly’s diabetes treatment Mounjaro, which is widely used for weight loss, raked in nearly $1 billion in second-quar...
Eli Lilly and Co. says its experimental Alzheimer's drug appears to slow worsening of the mind-robbing disease
Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients...
Eli Lilly fell well short of Wall Street’s first-quarter expectations, and the drugmaker chopped the top end of its earn...
Eli Lilly’s new COVID-19 treatment helped the drugmaker’s fourth-quarter profit surge even though U.S. regulators approv...
Drugmaker Eli Lilly says its COVID-19 antibody drug can prevent illness among residents and staff of nursing homes and o...
Shares of Eli Lilly have climbed after the drugmaker laid out a better-than-expected revenue forecast and plans to buy a...
Eli Lilly continues to back a potential COVID-19 treatment despite research showing that it may not work on hospitalized...
Eli Lilly and Co. is reporting third-quarter net income of $1.21 billion